需申請審核

RIDER Breast MRI

Ideally a patient’s response to neoadjuvant chemotherapy could be observed noninvasively, in the first 2-3 weeks of treatment using an imaging to provide feedback related to the effectiveness of the chosen chemotherapy regimen. This capability would permit individuation of patient care by supporting the opportunity to tailor chemotherapy to a each patient’s response. Functional diffusion mapping (fDM), now called Parametric Response Mapping (PRM) has been proposed as an MRI imaging biomarker for quantifying early brain tumor response to therapy [1-3]. This approach quantifies local apparent diffusion coefficient (ADC) changes in tumors using a voxel-based analysis implemented by rigid registration of the patient’s head between interval exams. The RIDER Breast MRI data set extended this approach by demonstrating ADC changes in 3 of 5 primary breast cancer patients measured in response to onset of neoadjuvant chemotherapy from interval exams separated by only 8-11 days. This ISMRM 2009 poster demonstrates how each of the "coffee break" exams were used as an estimate of each patient's null hypothesis, i.e. distribution associated with no change, and thus supports the estimate of the nulls 97.5 percentile for subsequent estimation of early response to neoadjuvant chemotherapy on an individual patient basis.

資料與資源

額外的資訊

欄位
最後更新 十二月 3, 2019, 13:21 (CST)
建立 十月 15, 2018, 20:52 (CST)

推薦資料集:


  • 屏東縣菸酒進口業者資料一覽表

    付費方式 免費
    更新頻率 不定期
    屏東縣菸酒進口業者資料
  • 高雄市湖內區107年公告地價

    付費方式 免費
    更新頻率 不定期
    107年-高雄市湖內區公告地價
  • 高雄市土地段名代碼

    付費方式 免費
    更新頻率 不定期
    提供高雄市土地段名代碼
  • 水位雨量站

    付費方式 免費
    更新頻率 不定期
    水位雨量站測站資訊
  • insight_test_16407

    付費方式 免費
    更新頻率 不定期